Last edition
News about Global Pharma
This new system features bipolar radiofrequency technology, and a new bipolar RF device called the Aveta Glo, representing a significant advancement in minimally invasive gynecologic procedures.
Global Pharma | 18/05/2024 | By Manvi | 929
Watkins-Conti Products Gets FDA Approval for Yoni.Fit Bladder Support
Yoni.Fit® is intended for the temporary management of urine leakage caused by stress urinary incontinence (SUI) in women, 18 years and older.
Global Pharma | 18/05/2024 | By Manvi | 434
Glenmark Secures ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
Glenmark Pharmaceuticals Ltd. has received final approval from the United States Food and Drug Administration (US FDA) for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2 percent|0.5 percent.
Global Pharma | 18/05/2024 | By Aishwarya | 426
Omega Laboratories Teams Up with Cannabix Technologies for Marijuana Breath Detection
Omega Laboratories has entered into a strategic partnership with Cannabix Technologies Inc., a pioneer in cannabis breathalyzer technology.
Global Pharma | 18/05/2024 | By Aishwarya | 299
Telo Genomics and Emery Pharma Announce Collaboration to Enhance Oncology Testing
This partnership aims to offer complementary cellular and molecular bioanalytical solutions for clinical research and development initiatives to their respective clients.
Global Pharma | 18/05/2024 | By Abha | 586
SII Invests in IntegriMedical to Boost N-FIS Technology
Serum Institute of India (SII) has made a strategic investment in IntegriMedical, acquiring a 20 percent stake in the company, to advance Needle-Free Injection System technology.
Global Pharma | 18/05/2024 | By Aishwarya | 547
Lupin Gets Approval from US FDA for Midostaurin Capsules
Lupin has secured approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Midostaurin Capsules.
Global Pharma | 18/05/2024 | By Aishwarya | 672
The EVIS X1 endoscopy system features imaging technologies designed to help physicians diagnose, treat and observe diseases and disorders of the upper and lower GI tract, including colorectal cancer.
Global Pharma | 17/05/2024 | By Manvi | 340
Johnson & Johnson to Acquire Proteologix to Expand its Portfolio
Johnson & Johnson has signed a definitive agreement to acquire Proteologix, Inc. for USD 850 million in cash, with the potential for an additional milestone payment.
Global Pharma | 17/05/2024 | By Aishwarya | 713
Bristol Myers Squibb Gets US FDA Approval for Breyanzi
Bristol Myers Squibb has declared that US Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi.
Global Pharma | 17/05/2024 | By Aishwarya | 758
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy